Concord Biotech Limited (BOM:543960)
2,013.45
+86.20 (4.47%)
At close: Jun 9, 2025
Concord Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
Cash & Equivalents | 11.83 | 151.42 | 34.99 | 6.67 | 51.44 | Upgrade
|
Short-Term Investments | 3,165 | 228.22 | 305.8 | 872.5 | 550 | Upgrade
|
Trading Asset Securities | - | 2,437 | 1,369 | 734.73 | 1,410 | Upgrade
|
Cash & Short-Term Investments | 3,177 | 2,817 | 1,710 | 1,614 | 2,011 | Upgrade
|
Cash Growth | 12.80% | 64.71% | 5.96% | -19.76% | 0.31% | Upgrade
|
Accounts Receivable | 5,217 | 3,496 | 2,738 | 2,322 | 1,775 | Upgrade
|
Other Receivables | - | 159.99 | 217.95 | 272.74 | 358.19 | Upgrade
|
Receivables | 5,217 | 3,656 | 2,956 | 2,594 | 2,133 | Upgrade
|
Inventory | 2,397 | 2,080 | 2,123 | 1,951 | 1,536 | Upgrade
|
Prepaid Expenses | - | 73.31 | 55.19 | 47.61 | 45.44 | Upgrade
|
Other Current Assets | 561.96 | 336.73 | 433.05 | 119.5 | 345.27 | Upgrade
|
Total Current Assets | 11,352 | 8,962 | 7,277 | 6,327 | 6,071 | Upgrade
|
Property, Plant & Equipment | 8,442 | 7,865 | 7,655 | 6,436 | 5,577 | Upgrade
|
Long-Term Investments | 187.26 | 20.7 | 79.25 | 2.56 | 3.66 | Upgrade
|
Other Intangible Assets | 11.22 | 3.2 | 1.98 | 35.77 | 64.18 | Upgrade
|
Other Long-Term Assets | 349.41 | 156.1 | 126.8 | 327.4 | 108.69 | Upgrade
|
Total Assets | 20,343 | 17,007 | 15,140 | 13,128 | 11,825 | Upgrade
|
Accounts Payable | 1,130 | 944.35 | 938 | 831.06 | 463.97 | Upgrade
|
Accrued Expenses | - | 168.21 | 146.19 | 131.45 | 102.38 | Upgrade
|
Short-Term Debt | - | - | - | 43.37 | 50.99 | Upgrade
|
Current Portion of Long-Term Debt | 3.81 | 62.3 | 250 | 250 | 250 | Upgrade
|
Current Portion of Leases | 19.58 | 16.21 | 1.47 | 15.96 | 13.01 | Upgrade
|
Current Income Taxes Payable | 101.27 | 54.94 | 89.99 | - | - | Upgrade
|
Current Unearned Revenue | - | - | 13.13 | 32.72 | - | Upgrade
|
Other Current Liabilities | 585.57 | 175.55 | 479.67 | 247.1 | 177.04 | Upgrade
|
Total Current Liabilities | 1,841 | 1,422 | 1,918 | 1,552 | 1,057 | Upgrade
|
Long-Term Debt | - | - | 62.36 | 312.49 | 562.5 | Upgrade
|
Long-Term Leases | 6.3 | 18.87 | 1.64 | 3.11 | 16.33 | Upgrade
|
Long-Term Deferred Tax Liabilities | 340.22 | 280.65 | 234.39 | 209.71 | 174.53 | Upgrade
|
Other Long-Term Liabilities | 28.2 | 19.56 | 22.97 | 18.74 | 20.98 | Upgrade
|
Total Liabilities | 2,215 | 1,741 | 2,240 | 2,096 | 1,832 | Upgrade
|
Common Stock | 104.62 | 104.62 | 104.62 | 95.11 | 95.11 | Upgrade
|
Additional Paid-In Capital | - | 819.71 | 819.71 | 829.22 | 829.22 | Upgrade
|
Retained Earnings | - | 14,342 | 11,976 | 10,108 | 9,069 | Upgrade
|
Comprehensive Income & Other | 18,023 | - | - | - | - | Upgrade
|
Shareholders' Equity | 18,127 | 15,266 | 12,900 | 11,032 | 9,994 | Upgrade
|
Total Liabilities & Equity | 20,343 | 17,007 | 15,140 | 13,128 | 11,825 | Upgrade
|
Total Debt | 29.69 | 97.38 | 315.46 | 624.93 | 892.83 | Upgrade
|
Net Cash (Debt) | 3,148 | 2,719 | 1,395 | 988.98 | 1,118 | Upgrade
|
Net Cash Growth | 15.75% | 94.98% | 41.02% | -11.58% | -24.66% | Upgrade
|
Net Cash Per Share | 30.08 | 25.99 | 13.33 | 9.45 | 10.69 | Upgrade
|
Filing Date Shares Outstanding | 104.61 | 104.62 | 104.62 | 104.62 | 104.62 | Upgrade
|
Total Common Shares Outstanding | 104.61 | 104.62 | 104.62 | 104.62 | 104.62 | Upgrade
|
Working Capital | 9,512 | 7,541 | 5,359 | 4,775 | 5,014 | Upgrade
|
Book Value Per Share | 173.28 | 145.93 | 123.31 | 105.45 | 95.53 | Upgrade
|
Tangible Book Value | 18,116 | 15,263 | 12,898 | 10,996 | 9,930 | Upgrade
|
Tangible Book Value Per Share | 173.18 | 145.90 | 123.29 | 105.11 | 94.91 | Upgrade
|
Land | - | 547.11 | 547.11 | 547.11 | 546.99 | Upgrade
|
Buildings | - | 2,576 | 2,463 | 2,226 | 1,981 | Upgrade
|
Machinery | - | 4,979 | 4,788 | 4,285 | 3,773 | Upgrade
|
Construction In Progress | - | 2,115 | 1,727 | 741.55 | 179.46 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.